Véronique Lecault, Ph.D.

Véronique Lecault, Ph.D.

Chief Technology OfficeratAbCellera Biologics· In proxies 2021–2025

Pay in FY2025-32% from the year before · AbCellera Biologics stock +16.7% the same year

Véronique Lecault, Ph.D. was paid $2.3M in FY2025 (Dec), down 32%. AbCellera Biologics stock rose 16.7% that year.

Pay$100 in the stock at the end of FY20 → $8
Pay is from the Summary Compensation Table of each AbCellera Biologics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AbCellera BiologicsPublic company · 5 yr
    • Chief Technology Officer2021 – Present · 5 yrStock in role -68%
  2. Trianni Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  3. Company’s Board of DirectorsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?